OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S

03-Feb-2012 - Netherlands

OctoPlus N.V.  announced that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S. The undisclosed contract value will make a material contribution to OctoPlus' 2012 revenues. Further details on the compound and activities are not disclosed.

Other news from the department business & finance

Most read news

More news from our other portals